AI-generated summary
The authors ran a single-arm pilot trial of six weeks of light therapy in 18 people with severe visual impairment or blindness who had recurrent winter depressive symptoms. Among the 12 who completed treatment, depression scores fell, and wellbeing and sleep quality improved, with half falling below the remission cut-off. Four participants with some residual sight had side effects, such as glare or altered vision, that led to dropout or exclusion.
- Participants
- 18
- Who or what was studied
- People with severe visual impairment or blindness who met screening criteria for seasonal affective disorder or subsyndromal seasonal affective disorder
- Limits stated in the abstract
- The trial was a small single-arm pilot with no control group, and the abstract notes that eye safety remains a concern for people with residual sight.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on cambridge.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Pilot study, Depression, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.